|
NextGen names Geoff Alms North America sales director, Gareth Thomson head of marketing
(Science Letter Via Thomson Dialog NewsEdge)
NextGen Group PLC, (NGG) a Cambridge, U.K.-based "gene-to-protein" company, announced it has appointed Geoff Alms, PhD, as sales director for North America and Gareth Thomson as head of marketing.
Alms joins NextGen Science Inc. from Upstate Inc., a division of Serologicals Corporation, where he was employed as director of sales for drug discovery, North America. While there, he drove the sales growth in the first 6 months post-acquisition and integration by over 55% and retained 100% of employees during the post-sale integration of the company. He completed his PhD and postdoctoral studies in pharmacology at the University of Virginia.
Alm's appointment along with three experienced salesmen completes the initial phase in the formation of a technically qualified sales team in the U.S. focused on the commercialization of NextGen's main gene to protein product range, which includes the Expression Workstation, a2DEoptimizer, OrchestratorIMS and the newly introduced ContractExpress fee for service business.
Thomson joins NextGen Group PLC as head of marketing from Affymetrix UK Ltd, where he was employed as the senior marketing manager. He has over 10 years experience in marketing and was responsible for the development and implementation of a regional marketing plan that included direct marketing campaigns, product launches and media placement. Prior to this he worked for Amersham-Pharmacia Biotech, now GE Healthcare, where he was responsible for major account management including Glaxo SmithKline and a number of academic institutes.
Thomson holds a bachelor of science degree in biological sciences from Salford University in Manchester, England.
This article was prepared by Science Letter editors from staff and other reports. Copyright 2006, Science Letter via NewsRx.com.
[ Back To TMCnet.com's Homepage ]
|